Loss of treatment benefit when heroin-assisted treatment is stopped after 12 month

Demaret, Isabelle; Quertemont, Etienne; Litran, Géraldine; Magoga, Cécile; Deblire, Clémence; DUBOIS, Nathalie; Charlier, Corinne; Lemaître, André; ANSSEAU, Marc

doi:10.1016/j.jsat.2016.06.005

Download

Article (Scientific journals)

Loss of treatment benefit when heroin-assisted treatment is stopped after 12 month

Demaret, Isabelle; Quertemont, Etienne; Litran, Géraldine et al.

2016 • In Journal of Substance Abuse Treatment, 69, p. 72-75

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/205503

DOI
10.1016/j.jsat.2016.06.005

PubMed
27568513

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

DEMARET_2016_LossOfTreatmentBenefit_JSAT.pdf

Publisher postprint (269.55 kB)

Download

http://www.journalofsubstanceabusetreatment.com/

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Heroin-assisted treatment,; diacetylmorphine; treatment duration; substitution treatment

Abstract :

[en] Purpose: In 2013, during a recent heroin-assisted treatment trial, participants in heroinassisted treatment (HAT) decreased significantly more their street heroin use than participants in oral methadone treatment. After the trial, HAT was discontinued. To examine whether the treatment benefits were sustained three months after the trial, the use of street heroin by the participants was analysed in a follow-up study. Results: At the follow-up assessment, street heroin use increased in the experimental group. The two groups no longer showed a significant difference (p=0.55) in the level of street heroin use. Conclusion: A predetermined and forced end of HAT was followed by a significant increase in the level of street level use.

Disciplines :

Psychiatry
Pharmacy, pharmacology & toxicology

Author, co-author :

Demaret, Isabelle ; Université de Liège > Faculté des sciences sociales > Criminologie

Quertemont, Etienne ; Université de Liège > Doyen de la Fac. de Psych., Logopédie et Sc. de l'Education

Litran, Géraldine

Magoga, Cécile

Deblire, Clémence

DUBOIS, Nathalie ; Centre Hospitalier Universitaire de Liège - CHU > Service de toxicologie

Charlier, Corinne ; Université de Liège > Département de pharmacie > Chimie toxicologique

Lemaître, André ; Université de Liège > Faculté des sciences sociales > Criminologie

ANSSEAU, Marc ; Centre Hospitalier Universitaire de Liège - CHU > Service de psychiatrie et psychologie médicale

Language :

English

Title :

Loss of treatment benefit when heroin-assisted treatment is stopped after 12 month

Publication date :

June 2016

Journal title :

Journal of Substance Abuse Treatment

ISSN :

0740-5472

eISSN :

1873-6483

Publisher :

Pergamon Press - An Imprint of Elsevier Science

Volume :

Pages :

72-75

Peer reviewed :

Peer Reviewed verified by ORBi

Additional URL :

http://www.journalofsubstanceabusetreatment.com/article/S0740-5472(15)30053-2/abstract

Available on ORBi :

since 18 January 2017

Statistics

Number of views

221 (7 by ULiège)

Number of downloads

260 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Ansseau, M, Gustin, F, Hodiaumont, F, Lemaître, A, Lo Bue, S, Lorant, V,. Van Deun, P, DHCo Délivrance d'héroïne sous contrôle médical: Etude de faisabilité et de suivi. 2005, Academia press, Gand, Belgique.
Blanken, P, Hendriks, VM, Van Ree, JM, Van Den Brink, W, Outcome of long-term heroin-assisted treatment offered to chronic, treatment-resistant heroin addicts in the Netherlands. Addiction 105 (2010), 300–308, 10.1111/j.1360-0443.2009.02754.x.
Demaret, I, Herné, P, Lemaître, A, Ansseau, M, Feasibility assessment of heroin-assisted treatment in Liège, Belgium. Acta Psychiatrica Belgica 111 (2011), 3–8.
Demaret, I, Lemaître, A, Ansseau, M, Staff concerns in heroin-assisted treatment centres. Journal of Psychiatric and Mental Health Nursing 19 (2012), 563–567, 10.1111/j.1365-2850.2011.01810.x.
Demaret, I, Litran, G, Magoga, C, Deblire, C, Dupont, A, De Roubaix, J,.. Ansseau, M, Why do heroin users refuse to participate in a heroin-assisted treatment trial?. Heroin Addiction and Related Clinical Problems 16 (2014), 41–48.
Demaret, I, Quertemont, E, Litran, G, Magoga, C, Deblire, C, Dubois, N,.. Ansseau, M, Efficacy of heroin-assisted treatment in Belgium: A randomised controlled trial. European Addiction Research 21 (2015), 179–187, 10.1159/000369337.
Ferri, M, Davoli, M, Perucci, CA, Heroin maintenance for chronic heroin-dependent individuals. Cochrane Database of Systematic Reviews, 12, 2011, CD003410, 10.1002/14651858.CD003410.pub4.
Gosselin, M, Bergeron, J, Evaluation des qualités psychométriques du questionnaire de santé mentale SCL-90-R. 1993, RISQ, Montréal, QC, 87.
Guttinger, F, Gschwend, P, Schulte, B, Rehm, J, Uchtenhagen, A, Evaluating long-term effects of heroin-assisted treatment: the results of a 6-year follow-up. European Addiction Research 9 (2003), 73–79, 10.1159/000068811.
Haasen, C, Verthein, U, Degkwitz, P, Berger, J, Krausz, M, Naber, D, Heroin-assisted treatment for opioid dependence: randomised controlled trial. The British Journal of Psychiatry 191 (2007), 55–62, 10.1192/bjp.bp.106.026112.
Khan, R, Khazaal, Y, Thorens, G, Zullino, D, Uchtenhagen, A, Understanding Swiss drug policy change and the introduction of heroin maintenance treatment. European Addiction Research 20 (2014), 200–207, 10.1159/000357234.
Kokkevi, A, Hartgers, C, EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence. European Addiction Research 1 (1995), 208–210, 10.1159/000259089.
March, JC, Oviedo-Joekes, E, Perea-Milla, E, Carrasco, F, PEPSA Team, Controlled trial of prescribed heroin in the treatment of opioid addiction. Journal of Substance Abuse Treatment 31 (2006), 203–211, 10.1016/j.jsat.2006.04.007.
Marsden, J, Gossop, M, Stewart, D, Best, D, Farrell, M, Lehmann, P,.. Strang, J, The Maudsley addiction profile (MAP): A brief instrument for assessing treatment outcome. Addiction 93 (1998), 1857–1867.
Oviedo-Joekes, E, Brissette, S, Marsh, DC, Lauzon, P, Guh, D, Anis, A, Schechter, MT, Diacetylmorphine versus methadone for the treatment of opioid addiction. The New England Journal of Medicine 361 (2009), 777–786, 10.1056/NEJMoa0810635.
Oviedo-joekes, E, Guh, D, Marchand, K, Marsh, DC, Lock, K, Brissette, S,.. Schechter, MT, Differential long-term outcomes for voluntary and involuntary transition from injection to oral opioid maintenance treatment. Substance Abuse Treatment, Prevention, and Policy, 2014, 3–9.
Oviedo-Joekes, E, March, JC, Romero, M, Perea-Milla, E, The Andalusian trial on heroin-assisted treatment: A 2 year follow-up. Drug and Alcohol Review 29 (2010), 75–80, 10.1111/j.1465-3362.2009.00100.x.
Oviedo-Joekes, E, Nosyk, B, Brissette, S, Chettiar, J, Schneeberger, P, Marsh, DC,.. Schechter, MT, The North American Opiate Medication Initiative (NAOMI): Profile of participants in North America's first trial of heroin-assisted treatment. Journal of Urban Health 85 (2008), 812–825, 10.1007/s11524-008-9312-9.
Pellet, J, La symptom check-list. Guelfi, J.D., (eds.) L'évaluation clinique standardisée en psychiatrie, 1997, Editions Médicales Pierre Fabre, Paris, 77–85.
Perneger, TV, Giner, F, del Rio, M, Mino, A, Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments. BMJ 317 (1998), 13–18, 10.1136/bmj.317.7150.13.
Rehm, J, Gschwend, P, Steffen, T, Gutzwiller, F, Dobler-Mikola, A, Uchtenhagen, A, Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: A follow-up study. Lancet 358 (2001), 1417–1420, 10.1016/S0140-6736(01)06529-1.
Strang, J, Metrebian, N, Lintzeris, N, Potts, L, Carnwath, T, Mayet, S,.. Forzisi, L, Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): A randomised trial. Lancet 375 (2010), 1885–1895, 10.1016/S0140-6736(10)60349-2.
van den Brink, W, Hendriks, VM, Blanken, P, Koeter, MWJ, van Zwieten, BJ, van Ree, JM, Medical prescription of heroin to treatment resistant heroin addicts: Two randomised controlled trials. BMJ, 327, 2003, 310, 10.1136/bmj.327.7410.310.
Verthein, U, Bonorden-Kleij, K, Degkwitz, P, Dilg, C, Köhler, WK, Passie, T,.. Haasen, C, Long-term effects of heroin-assisted treatment in Germany. Addiction 103 (2008), 960–968, 10.1111/j.1360-0443.2008.02185.x.
World Health Organization, Atlas on substance use (2010): Resources for the prevention and treatment of substance use disorders., 2010 (Retrieved 6 November 2015, from) http://www.who.int/substance_abuse/publications/treatment/en/.